Abstract:Abstract Purpose of the review The understanding of the cellular and molecular pathogenesis of allergic contact dermatitis (ACD) has increased dramatically. Recent findings Besides CD4+ and CD8+ T cells, other cell types such as innate lymphoid cells, natural killer T cells (NKT), natural killer cells, and T regulatory cells have emerged as crucial key players. New immunological insights have unravelled that the predominant effector cell type determines the clinical pictures. Hence, a better understanding of the involvement of distinct effector cells has shed light on the diversity of ACD reactions and subsequent clinical pictures. Another new perspective has arisen in the elicitation phase. Here, Langerhans cells can play a role in the development of immune tolerance and not, as previously thought, exclusively in the allergen-driven hypersensitivity reaction. B cells also appear to play an important role in triggering ACD by secreting IgM antibodies in response to interleukin (IL)-4 produced by NKT cells, leading to complement activation and chemotaxis of immune cells. Summary Allergic contact dermatitis is a delayed-type hypersensitivity reaction triggered by skin contact with the chemical of interest in individuals previously sensitised to the same or a chemically related substance. The understanding of the cellular and molecular pathogenesis of allergic contact dermatitis has improved considerably. In addition to CD4+ and CD8+ T cells, other cell types such as natural killer T cells (NKT) and regulatory T cells have emerged as important participants. The binding of haptens is the first step in the development of allergic contact dermatitis. Haptens are low molecular weight (mostly <500 Dalton) chemicals that are able to penetrate the stratum corneum of the skin or can enter the body upon systemic administration. Haptens are not immunogenic per se but can be effectively recognised by the immune system after binding to a protein carrier. In the clinically inapparent sensitisation phase, Langerhans cells and dendritic cells initiate an adaptive immune response by capturing and processing antigens and presenting them to naïve T cells in the paracortical regions of the lymph nodes. In the elicitation phase, the clinical manifestations of allergic contact dermatitis are the result of a T cell-mediated inflammatory response that occurs in the skin upon re-exposure to the bite and is mediated by the activation of bite-specific T cells in the skin or other organs.

Hapten Application to the Skin Induces an Inflammatory Program Directing Hapten-Primed Effector CD8 T Cell Interaction with Hapten-Presenting Endothelial Cells

IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses.

P‐selectin Directs T Lymphocyte‐mediated Injury in Delayed‐type Hypersensitivity Responses: Studies in Glomerulonephritis and Cutaneous Delayed‐type Hypersensitivity

Tolerogenic phenotype of dendritic cells is induced after hapten sensitization followed by attenuated contact hypersensitivity response in atopic dermatitis model NC/Nga mice

Structure-Immune Response Relationships Of Hapten-Modified Collagen Ii Peptides In A T-Cell Model Of Allergic Contact Dermatitis

CD8+ Tc1 and TIL-17 cells mediate allergic contact hypersensitivity by different mechanisms

CD8+ Tc1 and TIL-17 Cells Mediate Allergic Contact Hypersensitivity by Different Mechanisms (37.18)

Immunological Mechanisms in Allergic Contact Dermatitis

Pathomechanisms of Contact Sensitization

Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity

Natural killer T cells are essential for the development of contact hypersensitivity in BALB/c mice

Cytotoxic T cell responses to haptenated cells. IV. Requirements for in vivo priming

Hapten-Induced Contact Hypersensitivity, Autoimmune Reactions, and Tumor Regression: Plausibility of Mediating Antitumor Immunity

Influence of Th2 cells on hair cycle/growth after repeated cutaneous application of hapten

An Essential Role for Tak1 in the Contact Hypersensitivity Response

Innate immunity and effector and regulatory mechanisms involved in allergic contact dermatitis

Induction of Tolerance to Urushiol by Epicutaneous Application of This Hapten on Dinitrofluorobenzene-Treated Skin

IFN-γ–dependent Interactions Between Tissue-Intrinsic Γδ T Cells and Tissue-Infiltrating CD8 T Cells Limit Allergic Contact Dermatitis

The clonal structure and dynamics of the human T cell response to an organic chemical hapten

Epicutaneous application of protein antigens incorporated into cosmetic cream induces antigen-nonspecific unresponsiveness in mice and affects the cell-mediated immune response

Chemokine expression in diverse nonimmediate drug hypersensitivity reactions: focus on thymus activation-regulated chemokine, cutaneous T-cell-attracting chemokine, and interleukin-10.